Skip to main content
SpringerLink
Log in

The Immunotherapy of HIV Infection with Drugs

  • Chapter
Immunology of HIV Infection

Abstract

The history of the effort to treat HIV infection with immunotherapeutic drugs has been a frustrating one. Soon after the onset of this epidemic in 1981, there were extensive efforts to use a long list of drugs being employed in cancer immunotherapy to treat AIDS. As predicted (Hadden, 1985), these attempts failed (Hadden, 1991; Specter and Hadden, 1992). The problem, quite simply, related to the predicted inability of any drug to increase T-cell number by any mechanism other than the inhibition of HIV replication. In approaching this discussion, I recognize that this topic is not in vogue. In fact, in some recent reviews, the subject of immunotherapeutic drugs is not even mentioned (Laurence, 1995; Lederman, 1995). I take a different view (Hadden, 1991). I would contend that the efforts using some of the drugs have taught that not only are they safe but also that they can reduce the development of AIDS-defining clinical events and can often delay the predicted decline in CD4 T lymphocytes. Nevertheless, the efforts have not demonstrated a convincing mechanism of action. The problem remains to be properly phrased: What can immunotherapeutic drugs be expected to do for HIV infection? and How do we measure the effect by other than clinical endpoints?, i. e., how can we prove the mechanism of action? It will be the purpose of this chapter to review the progress of efforts to employ such drugs in HIV infection prior to the development of AIDS and to delineate prospects for better defining and improving such treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Abrams, D., Cotton, D., and Mayer, K., eds., 1995, AIDS/HIV Treatment Directory Vol. 7, No. 4.

    Google Scholar 

  • Addo, E., McFarlane, H., and Parsad, K., 1989, ACTH-inosine pranobex in the treatment of AIDS. Encouraging results, West Indian Med. J. 38:142–147.

    PubMed  CAS  Google Scholar 

  • Ahuja, K., Manvar, D., Reddy, M., Moriarty, M., and Grieco, M. H., 1983, Cimetidine as an immunomodulating agent in the A.I.D. syndrome, J. Allergy Clin. Immunol. 71:132.

    Article  Google Scholar 

  • Barcellini, W., Meroni, P. L., Frasca, D., Squotti, C., Borghi, M. O., Uberti-Foppa, C., Buzzetti, P., Lazzarin, A., Doria, G., Moroni, M., and Zanussi, C., 1987, Effect of subcutaneous thymopentin treatment in drug addicts with persistent generalized lymphadenopathy, Clin. Exp. Immunol. 67:537–543.

    PubMed  CAS  Google Scholar 

  • Bekesi, J. G., Tsang, P. H., Wallace, J. I., and Roboz, J. P., 1987, Immunorestorative properties of isoprinosine in the treatment of patients at high risk of developing ARC or AIDS, J. Clin. Lab. Immunol. 24:155–161.

    PubMed  CAS  Google Scholar 

  • Birx, D. L., and Redfield, R., 1991, HIV vaccine therapy, Int. J. Immunopharmacol. 13:129–132.

    Article  PubMed  Google Scholar 

  • Blackboum, D. J., Mackewicz, C., Barker, E., and Levy, J. A., 1994, Human CD8+ cell non-cytolytic anti-HIV activity mediated by a novel cytokine, Res. Immunol 145:653–658.

    Article  Google Scholar 

  • Brockmeyer, N. H., Kreuzfelder, E., Mertins, L., Chalabi, N., Kirch, W., Scheiermann, N., Goos, M., and Ohnhaus, E. E., 1988, Immunomodulatory properties of cimetidine in ARC patients, Clin. Immunol. Immunopathol. 48:50–60.

    Article  PubMed  CAS  Google Scholar 

  • Carey, J. T., Lederman, M. M., Tossii, Z., Edmonds, K., Hodder, S., Calabrese, L. H., Proffitt, M. R., Johnson, C. E., and Ellner, J. J., 1987, Augmentation of skin test reactivity and lymphocyte blastogenesis in patients with AIDS treated with transfer factor, J. Am. Med. Assoc. 257:651–655.

    Article  CAS  Google Scholar 

  • Carter, W. A., Brodsky, I., Pellegrino, M. G., Henriques, H. R., Parenti, D. M. Schulof, R. S., Robinson, E. W., Volsky, D. J., Paxton, H., Kariko, K., Suhadolnik, R. J., Strayer, D. R., Lewin, M., Einck, L., Simon, G. L., Scheib, R. G., Montefiori, D. C., Mitchell, W. M., Paul, D., Meyerin, W. A., Reichenbach, N., and Gillespie, D. H., 1987, Clinical, immunological and virological effects of ampligen, a mismatched double-stranded RNA in patients with AIDS or AIDS-related complex, Lancet 6:1286–1292.

    Article  Google Scholar 

  • Carter, W. A., Ventura, D., Shapiro, D. E., Strayer, D. R., Gillespie, D. H., and Hubbell, H. R., 1991, Mismatched double-stranded RNA, ampligen (poly(I):poly(C12U)), demonstrates antiviral and immunostimulatory activities in HIV disease, Int. J. Immunopharmacol. 13:69–76.

    Article  PubMed  CAS  Google Scholar 

  • Chachoua, A., Hochster, H., Green, M., Ward, C., Gutknecht, G., Chuang-Stein, C., Nicholas, J., and Merritt, J., 1988, Phase II trial of bropirimine in patients with AIDS related Kaposi’s sarcoma, Proc. Am. Soc. Clin. Oncol. 7:6 (abstract).

    Google Scholar 

  • Chirmule, N., Kalynanaraman, V., and Pahwa, S., 1988, Suppression of antigen specific lymphoproliferation by the envelope glycoproteins of the human immunedeficiency virus, FASEB J. 46:A906.

    Google Scholar 

  • Ciobanu, N., Weite, K., Kruger, G., Ventuta, S., Gold, J., Feldman, S. P., Wang, C. Y., Koziner, B., Moore, M. A. S., Safai, B., and Mertelsmann, R., 1983, Defective T-cell response to PHA and mitogenic monoclonal antibodies in male homosexuals with acquired immunodeficiency syndrome and its in vitro correction by interleukin 2, J. Clin. Immunol. 3:332–340.

    Article  PubMed  CAS  Google Scholar 

  • Clerici, M., and Shearer, G. M., 1993, A TH1-TH2 switch is a critical step in the etiology of HIV infection, Immunol. Today 14:107–111.

    Article  PubMed  CAS  Google Scholar 

  • Clerici, M., and Shearer, G. M., 1994, The TH1-TH2 hypothesis of HIV infection: New insights, Immunol. Today 15:575–581.

    Article  PubMed  CAS  Google Scholar 

  • Clerici, M., Levin, J. M., Kessler, H. A., Harris, A., Berzofsky, J. A., Landay, A. L., and Shearer, G. M., 1994a, HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood, J. Am. Med. Assoc. 271:42–46.

    Article  CAS  Google Scholar 

  • Clerici, M., Wynn, T. A., Berzofsky, J. A., Blatt, S. P., Hendrix, C. W., Sher, A., Coffman, R. L., and Shearer, G. M., 1994b, Role of IL-2 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus, J. Clin. Invest. 93:768–775.

    Article  PubMed  CAS  Google Scholar 

  • Conant, M. A., Goldstein, G., Hirsch, R. L., Meyerson, L. A., and Kremer, A. B., 1990, The effect of thymopentin treatment on progression of disease and surrogate markers in HIV-infected patients without AIDS. (UCLA Symposia on Molecular and Cell Biology, San Francisco AIDS Meeting Abstract #L411.) J. Cell. Biochem. (Suppl.) 14D:148.

    Google Scholar 

  • De Simone, C., Albertini, F., Almaviva, M., Angarano, P., Chiodo, F., Costigliola, P., Delia, S., Ferlini, A., Gritti, F., Mazzarello, G., Milazzo, F., Montroni, M., Narciso, P., Pastore, G., Raise, E., Santini, G., Sorice, F., Terragna, A., Visco, G., and Vullo, V., 1988, Clinical and immunological assessment in HIV+ subjects receiving inosine-pranobex: A randomized, multicentric study, Med. Oncol. Tumor Pharmacother. 10:299–303.

    Google Scholar 

  • Falloon, J., Ogata-Arakaki, D., Baseler, M., Graziani, A., Armantea, M. A., and Davey, R. T., 1990, Therapy of HIV infection with AS-101 and zidovudine, Abstract, 6th Int. Conf. AIDS.

    Google Scholar 

  • Glasky, A. J., and Gordon, J., 1986, Inosiplex treatment of acquired immundeficiencies: A clinical model for effective immunomodulation, Methods Fundam. Exp. Clin. Pharmacol. 8:35–40.

    CAS  Google Scholar 

  • Goldstein, G., Conant, M. A., Beall, G., Grossman, H. A., Galpin, J. E., Blick, G., Calabrese, L. H., Hirsch, R. L., Fisher, A., Stampone, P., and Meyerson, L. A., 1995, Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cell/mm3: A double-blind placebo-controlled trial, J. Acq. Immune Defic. Syndr. Hum. Retrovirol. 8:279–288.

    Article  CAS  Google Scholar 

  • Good, R. A., Haraguchi, S., Lorenz, E., and Day, N. K., 1991, In vitro immunomodulation and in vivo immuno-therapy of retrovirus-induced immunosuppression, Int. J. Immunopharmacol. 13:1–8.

    Article  PubMed  CAS  Google Scholar 

  • Goodwin, J. S., and Webb, D. R., 1980, Regulation of the immune response by prostaglandins, Clin. Immunol. Immunopathol. 15:106–109.

    Article  PubMed  CAS  Google Scholar 

  • Gottlieb, A. A., 1991, Clinical and immunologic observations in patients with AIDS-related complex treated with IMREG-1, Int. J. Immunopharmacol. 13:29–32.

    Article  PubMed  Google Scholar 

  • Gottlieb, A. A., and Trial Investigators, 1988, A phase 3 controlled trial of ImReg 1 in AIDS/ARC patients, 4th Int. Conf. AIDS, Stockholm, June.

    Google Scholar 

  • Gottlieb, M. S., Zackin, R. A., Fiala, M., Henry, D. H., Marcel, A. J., Combs, K. L., Vieira, J., Liebman, H. A., Cone, L. A., Hillman, B. A., and Gottlieb, A. A., 1991, Response to treatment with the leukocyte-derived immunomodulator IMREG-1 in immunocompromised patients with AIDS-related complex, Ann. Intern. Med. 115:84–91.

    Article  PubMed  CAS  Google Scholar 

  • Gurley, R. J., Keuchi, K., Byrn, R. A., Anderson, K., and Groopman, J. E., 1989, CD4 lymphocyte function with early human immunodeficiency virus infection, Proc. Natl. Acad. Sci. USA 86:1993–1997.

    Article  PubMed  CAS  Google Scholar 

  • Hadden, E. M., Wang, Y., Sosa, M., Coffey, R. G., Giner-Sorolla, A., and Hadden, J. W., 1995, Methyl inosine monophosphate (MIMP) augments T lymphocyte mitogen responses and reverses various immunosuppressants, Int. J. Immunopharmacol. 17:763–770.

    Article  PubMed  CAS  Google Scholar 

  • Hadden, J. W., 1985a, Thymomimetic drugs, in: Serono Symposium on Immunopharmacology, Volume 23 (P. A. Miescher, L. Bolis, and M. Ghione, eds.), Raven Press, New York, pp. 183–192.

    Google Scholar 

  • Hadden, J. W., 1985b, Perspective on the immunotherapy of AIDS, Ann. NY. Acad. Sci. 437:76–84.

    Article  Google Scholar 

  • Hadden, J. W., 1991, Immunotherapy of human immunodeficiency virus (HIV), Trends Pharmacol Sci. 12:107–111.

    Article  PubMed  CAS  Google Scholar 

  • Hadden, J. W., 1994, T-cell adjuvancy, Int. J. Immunopharmacol. 16:703–710.

    Article  PubMed  CAS  Google Scholar 

  • Hadden, J. W., and Coffey, R. G., 1990, Early biochemical events in the activation of T lymphocytes by mitogenic agents, in: Immunopharmacology Reviews I (J. W. Hadden and A. Szentivanyi, eds.), Plenum Press, New York, pp. 273–376.

    Chapter  Google Scholar 

  • Hadden, J. W., Coffey, R. G., Hadden, E. M., Lopez-Corrales, E., and Sunshine, G. H., 1975, Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levels, Cell. Immunol. 20:98–103.

    Article  PubMed  CAS  Google Scholar 

  • Hadden, J. W., Specter, S., Galy, A., Touraine, J. L., and Hadden, J. W., 1986, Thymic hormones, interleukins, endotoxins and thymomimetic drugs in T lymphocyte ontogeny, in: Advances in Immunopharmacology HI (L. Chedid, J. W. Hadden, F. Spreafico, P. Dukor, and D. Willoughby, eds.), Pergamon Press, Elmsford, NY, pp. 487–497.

    Google Scholar 

  • Hadden, J. W., Giner-Sorolla, A., and Hadden, E. M., 1991, Methyl inosine monophosphate (MIMP), a new purine immunomodulator for HIV infection, Int. J. Immunopharmacol. 13:49–54.

    Article  PubMed  CAS  Google Scholar 

  • Hadden, J. W., Ongradi, J., Specter, S., Nelson, R., Sosa, M., Strand, M., Giner-Sorolla, A., and Hadden, E. M., 1992, Methyl inosine monophosphate (MIMP): A potential immunotherapeutic for early HIV infection, Int. J. Immunopharmacol. 14:555–563.

    Article  PubMed  CAS  Google Scholar 

  • Haraguchi, S., Good, R. A., James-Yarish, M., Cianciolo, G. J., and Day, N. K., 1995, Induction of intracellular cAMP by a synthetic retroviral envelope peptide: A possible mechanism of immunopathogenesis in retroviral infections, Proc. Natl. Acad. Sci. USA 92:5568–5571.

    Article  PubMed  CAS  Google Scholar 

  • Hersh, E. M., Funk, C. Y., Peterson, E. A., and Mosier, D. E., 1991a, Effective therapy of the LP-BM5 murine retroviruse-induced lymphoproliferative disease with diethyldithiocarbamate, AIDS Res. Hum. Retrovir. 7:553–561.

    Article  PubMed  CAS  Google Scholar 

  • Hersh, E. M., Brewton, G., Abrams, D., Bartlett, J., Galpin, J., Gill, P., Gorter, R., Gottlieb, M., Jonikas, J. J., Landesman, S., Levine, A., Marcel, A., Peterson, E. A., Whiteside, M., Zahradnik, J., Negron, C., Boutitic, F., Caraux, J., Dupuy, J.-M., and Salmi, L. R., 1991b, Ditiocarb sodium (diethyldithiocarbamate) therapy in patients with asymptomatic HIV infection and AIDS. A randomized, double-blind, placebo-controlled, multicenter study, J. Am. Med. Assoc. 265:1538–1544.

    Article  CAS  Google Scholar 

  • The HIV-87 Study Group, 1993, Multicenter, randomized, placebo-controlled study of ditiocarb (Imuthiol) in human immunodeficiency virus-infected asymptomatic and minimally symptomatic patients, AIDS Res. Hum. Retrovir. 9:83–89.

    Article  Google Scholar 

  • Ho, D. D., Moudgil, T., and Alam, M., 1989, Quantitation of human immunodeficiency virus type I in the blood of infected persons, N. Engl. J. Med. 321:1621–1625.

    Article  PubMed  CAS  Google Scholar 

  • Ho, D. D., Neumann, A. U., Perelson, A. S., Chen, W., Leonard, J. M., and Markowitz, M., 1995, Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection, Nature 373:123–126.

    Article  PubMed  CAS  Google Scholar 

  • Hofmann, B., Nishanian, P., Nguyen, T., Liu, M., and Fahey, J. L., 1993a, Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues, AIDS 7:659–664.

    Article  PubMed  CAS  Google Scholar 

  • Hofmann, B., Nishanian, P., Nguyen, T., Insixiengmay, P., and Fahey, J. L., 1993b, Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes, Proc. Natl. Acad. Sci. USA 90:6676–6680.

    Article  PubMed  CAS  Google Scholar 

  • Kahn, J. O., Allan, J. D., Hodges, T. L., Kaplan, L. D., Arri, C. J., Fitch, H. F., Izu, A. E., Mordenti, J., Sherwin, S. A., Groopman, J. E., and Volderding, P. A. 1990, The safety and pharmacokinetics of recombinant soluble CD4 (rCD4) in subjects with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, Ann. Intern. Med. 112:254–261.

    Article  PubMed  CAS  Google Scholar 

  • Kaplan, C. S., Peterson, E. A., Yokum, D., and Hersh, E. M., 1989, A randomized controlled dose response study of intravenous sodium diethyldithiocarbamate in patients with advanced human immunodeficiency virus infection, Life Sci. 45:iii–ix.

    Article  PubMed  CAS  Google Scholar 

  • Keadle, T. L., Daniel, S., Rouse, B. T., and Horohov, D. W., 1996, Virus induced immunosuppression, in: Immunopharmacology Reviews, Vol. 2, pp. 131–156. (J. W. Hadden and A. Szentivanyi, eds.), Plenum Press, New York.

    Chapter  Google Scholar 

  • Kirkpatrick, C. H., Davis, K. C., Horsburgh, C. R., Cohn, D. L., Penley, K., and Judson, K. N., 1985, Interleukin 2 production by persons with the generalized lymphadenopathy syndrome or the acquired immune deficiency syndrome, J. Clin. Immunol. 5:31–37.

    Article  PubMed  CAS  Google Scholar 

  • Kotier, D. P., and Reka, S., 1990, Modulation of HIV production by rectal mucosa in vitro, Gastroenterology 98:457a.

    Google Scholar 

  • Kovacs, J. A., Baseler, M., Dewar, R. J., Vogel, S., Davey, R. T., Jr., Falloon, J., Polis, M. A., Walker, R. E., Stevens, R., Salzman, N. P., Metcalf, J. A., Masur, H., and Lane, H. C., 1995, Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection, N. Engl. J. Med. 332:567–575.

    Article  PubMed  CAS  Google Scholar 

  • Landay, A. L., Mackewicz, C. E., and Levy, J. A., 1993, An activated CD8+ T cell phenotype correlates with anti-HIV activity and asymptomatic clinical status, Clin. Immunol. Immunopathol. 69:106–116.

    Article  PubMed  CAS  Google Scholar 

  • Lang, J., Trepo, C., Kirstetter, M., Herrou, L., Retornaz, G., Renoux, G., Musset, M., Touraine, J. L., Choutet, P., Falkenroot, A., Liurdset, J. M., Touraine, F., Renoux, M., Caraux, J., and The AIDS Imuthiol French Study Group, 1988, Randomized and double-blind placebo-controlled trial of ditiocarb sodium (Imuthiol) in human immunodeficiency virus infection, Lancet 9:702–706.

    Article  Google Scholar 

  • LaPorte, J. P., Gonzalez, C., and Lebas, J., 1989, A new immunomodulating compound (AS101) in the treatment of AIDS, 5th Int. Conf. AIDS, Montreal p. 399, abstract.

    Google Scholar 

  • Laurence, J., 1995, Immune reconstitution in HIV/AIDS: Concepts and strategies, The AIDS Reader pp. 52-59.

    Google Scholar 

  • Lederman, M., 1995, Host factor-directed immunotherapies, The AIDS Reader pp. 64-68.

    Google Scholar 

  • Mackewicz, C., and Levy, J. A., 1992, CD8+ cell anti-HIV activity: Nonlytic suppression of virus replication, AIDS Res. Hum. Retrovir. 8:1039–1050.

    Article  PubMed  CAS  Google Scholar 

  • McMahon, D., Winklestein, A., Huang, X.-L., Armstrong, J., Pazin, G., Rinaldo, C., Tripoli, C., and Ho, M., 1992, Acute reactions associated with the infusion of ampligen, AIDS 6:235–236.

    PubMed  CAS  Google Scholar 

  • Merigan, T. C., Fisher, A. C., Goldstein, G., Winters, M. A., Meyerson, L. A., and Hirsch, R. L., 1995, Evaluation of codon 215 mutation, viral load, P24 and CD4 as prognostic factors in asymptomatic HIV infected subjects treated with thymopentin, J. Acq. Immune Defic. Syndr. Hum. Retrovir. 8:279–288.

    Article  Google Scholar 

  • Nielson, H. J., Svenningsen, A., Moesgaard, F., Georgsen, J., Pedersen, C., Mathiesen, L., Dickmeiss, E., Nielsen, J. O., and Kehlet, H., 1991, Ranitidine improves certain cellular immune responses in asymptomatic HIV-infected individuals, J. Acq. Immune Defic. Syndr. 4:577–584.

    CAS  Google Scholar 

  • Pahwa, S., Pahwa, R., Good, R. A., Gallo, R. C., and Saxinger, C., 1986, Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes, Proc. Natl. Acad. Sci. USA 83:9124–9128.

    Article  PubMed  CAS  Google Scholar 

  • Pantaleo, G., Graziosi, C., Demarest, J. F., Butini, L., Montroni, M., Fox, C. H., Orenstein, J. M., Kotler, D. P., and Fauci, A. S., 1993, HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease, Nature 362:355–358.

    Article  PubMed  CAS  Google Scholar 

  • Park, B. Y., and Good, R. A., 1975, Quantitative assessment of thymus-dependent T-cell function in human peripheral blood, Birth Defects 11:10–11.

    PubMed  CAS  Google Scholar 

  • Pederson, E. C., Sandstrom, E., Peterson, C. S., Norkrans, G., Gerstoft, J., Karlsson, J. O., Jurgenson, H. J., Christianson, K. C., Hakansson, C., Pehrson, P. O., Nielson, H. J., and the candinavian Isoprinosine Study Group, 1990, The efficacy of inosine pranobex in preventing the acquired immunodeficiency syndrome in patients with human immunodeficiency virus infection, N. Engl. J. Med. 322:1757–1763.

    Article  CAS  Google Scholar 

  • Reddy, M. M., Manvar, D., Ahuja, K. K., Moriarty, M. L., and Grieco, M. H., 1985, Augmentation of mitogen-induced proliferative responses by in vitro indomethacin in patients with acquired immune deficiency syndrome and AIDS-related complex, Int. J. Immunopharmacol. 7:917–921.

    Article  PubMed  CAS  Google Scholar 

  • Redfield, R. R., Birx, D. L., Ketter, N., Tramont, E., Polonis, V., Davis, C., Brundage, J. F., Smith, G., Johnson, S., Fowler, A., Wierzba, T., Shafferman, A., Volovitz, F., Oster, C., Burke, D. S., and the Military Medical Consortium for Applied Retroviral Research, 1991, A Phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection, N. Engl. J. Med. 324:1677–1684.

    Article  PubMed  CAS  Google Scholar 

  • Reisinger, E. A., Kern, P., Ehrst, M., Bock, P., Rao, H. D., Dietrich, M., and German DTC Study Group, 1990, Inhibition of HIV progression by dithiocarb, Lancet 335:679–682.

    Article  PubMed  CAS  Google Scholar 

  • Renoux, G., and Renoux, M., 1984, Diethyldithiocarbamate (DTC): A biological augmenting agent specific for T cells, in: Immune Modulation Agents and Their Mechanisms (R. L. Fenichel and M. A. Chirigos, eds.), Dekker, New York, p. 7.

    Google Scholar 

  • Rozzo, S. J., and Kirkpatrick, C. H., 1992, Purification of transfer factors, Mol. Immunol. 74:167–182.

    Article  Google Scholar 

  • Ruegg, C. L., and Engleman, E. G., 1990, Impaired immunity in AIDS: The mechanisms responsible and their potential reversal by antiviral therapy. Ann. N.Y. Acad. Sci. 616:307–317.

    Article  PubMed  CAS  Google Scholar 

  • Ruegg, C. L., and Strand, M., 1991, A synthetic peptide with sequence identity to the transmembrane protein PG41 of HIV-1 inhibits distinct lymphocyte activation pathways dependent on protein kinase C and intracellular calcium influx, Cell. Immunol. 137:1–13.

    Article  PubMed  CAS  Google Scholar 

  • Ruegg, C. L., Monell, C. R., and Strand, M., 1989, Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lympho-proliferation and its similarity to gp21 of human T lymphotropic virus types I and II, J. Virol. 63:3250–3256.

    PubMed  CAS  Google Scholar 

  • Ruiz-Palacios, G. M., Ponce de Leon, A., Alacon-Segovia, D., Calva, E., and Vasquez, M., 1988, Tolerance and clinical response to AS101, a new immunomodulator in AIDS patients, IV Int. Conf. AIDS, Stockholm p. 229.

    Google Scholar 

  • Schooley, R. T., Merigan, T. C., Gaut, P., Hirsch, M. S., Holodniy, M., Flynn, T., Liu, S., Byington, R. E., Henochowicz, S., Gubish, E., Spriggs, D., Kufe, D., Schindler, J., Dawson, A., Thomas, D., Hanson, D. G., Letwin, B., Liu, T., Gulinello, J., Kennedy, S., Fisher, R., and Hi, D. D., 1990, Recombinant soluble CD4 therapy in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex, Ann. Intern. Med. 112:247–253.

    Article  PubMed  CAS  Google Scholar 

  • Schwartz, D. H., Skowron, G., and Merigan, T. C., 1991, Safety and effects of IL-2 plus zidovudine in a tomatic individuals infected with human immunodeficiency virus, J. Acq. Immune Defic. Syndr. 4:11–23.

    CAS  Google Scholar 

  • Shibata, M., Hoon, D., Okun, E., and Morton, D., 1992, Modulation of histamine type II receptors on CD8+ T cells by interleukin 2 and cimetidine, Int. Arch. Allergy Appl. Immunol. 97:8–16.

    Article  CAS  Google Scholar 

  • Siegal, J. P., Djeu, J., Stocks, N. L., Masur, H., Gelmann, E. P., and Quinnan, G. V., Jr., 1985, Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin 2 by normal lymphocytes, J. Clin. Invest. 75:1957–1964.

    Article  Google Scholar 

  • Silvestris, F., Germone, A., Frassanito, M., and Dammacco, F., 1989, Immunologie effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome, J. Lab. Clin. Med. 113:139–144.

    PubMed  CAS  Google Scholar 

  • Sinha, S. K., Sizemore, R. C., and Gottlieb, A. A., 1988, Immunomodulatory components present in ImReg-1, an experimental immunosupportive biologic, Biotechnology 6:810–815.

    Article  CAS  Google Scholar 

  • Sizemore, R. C., Dienglewicz, R. L., Pecunia, E., and Gottlieb, A. A., 1991, Modulation of concanavalin A-induced, antigen-nonspecific regulatory cell activity by Leu-enkephalin and related peptides, Clin. Immunol. Immunopathol. 60:310–318.

    Article  PubMed  CAS  Google Scholar 

  • Snyderman, R., and Cianciolo, G. J., 1984, Immunosuppressive activity of the retroviral envelope protein P15E and its possible relationship to neoplasia, Immunol. Today 5:240–244.

    Article  CAS  Google Scholar 

  • Sosa, M., Sana, A. R., Wang, Y., Wadsworth, T., Coto, J. A., Giner-Sorolla, A., Hadden, E. M., and Hadden, J. W., 1992, Potentiation of immune responses in mice by a new inosine derivative—Methyl inosine monophosphate (MIMP), Int. J. Immunopharmacol. 14:1259–1266.

    Article  PubMed  CAS  Google Scholar 

  • Specter, S., and Hadden, J. W., 1992, Immunotherapy for acquired immunodeficiency syndrome: Status and prospects, in: AIDS and Other Manifestations of HIV Infection (G. Wormser, ed.), Raven Press, New York, pp. 625–632.

    Google Scholar 

  • Sunshine, G., Basch, R. S., Coffey, R. G., Cohen, K. W., Goldstein, G., and Hadden, J. W., 1978, Thymopoietin enhances the allogenic response and cyclic nucleotide levels of mouse peripheral, thymus-derived lymphocytes, J. Immunol. 120:1594–1599.

    PubMed  CAS  Google Scholar 

  • Svedersky, L., Roey, S., Scillian, J., Goldyne, M., Moody, D., and Stites, D., 1990, Prostaglandin production is related to decreased lymphocyte responses in HIV-infected individuals, FASEB J. 7(4), ASBMG-AAI Meeting, New Orleans, abstract #3284.

    Google Scholar 

  • Turowski, R. C., and Triozzi, P. L., 1994, Application of chemical immunomodulators to the treatment of cancer and AIDS, Cancer Invest. 12:620–643.

    Article  PubMed  CAS  Google Scholar 

  • Wilson, G. B., Paddock, G. V., and Fudenberg, H. H., 1979, The chemical nature of the antigen-specific moiety of transfer factor, Trans. Assoc. Am. Physicians 92:239–256.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Division of Immunopharmacology, University of South Florida Medical College, Tampa, Florida, 33612, USA

    John W. Hadden

Authors
  1. John W. Hadden
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of California, Irvine, California, USA

    Sudhir Gupta M.D., Ph.D.

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hadden, J.W. (1996). The Immunotherapy of HIV Infection with Drugs. In: Gupta, S. (eds) Immunology of HIV Infection. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-0191-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-0191-0_24

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-0193-4

  • Online ISBN: 978-1-4899-0191-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation